KNSA vs SJM · P/E 53, rev $677.6M vs rev $9.05B
Kiniksa Pharmaceuticals Ltd (KNSA) versus JM Smucker Company (SJM) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
JM Smucker Company (SJM) is a packaged foods company listed on US.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported SJM revenue for 2026-04-30 was $9.05B. Net income was -$138.7M. Revenue was up 3.7% from 2025-04-30 to 2026-04-30. SJM currently screens at market cap $11.10B.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. SJM currently screens at market cap $11.10B.
Not investment advice. Open the KNSA and SJM stock pages for the full models.
Not investment advice.